Jun 15, 2022, 09:29 AM by

Creative Biogene announced the release of Bacillus subtilis cultivation service using flexible fermentation and cultivation strategies to help customers in obtaining high-yield and bioactive B. subtilis bioproducts.

Jun 15, 2022, 09:29 AM by

MOBILion Systems Inc. delivers technical presentations and unveils new applications areas for its HRIM instrument, MOBIE, at ASMS 2022.

Jun 15, 2022, 09:29 AM by

mdgroup appoints LaQuinta Jernigan as Chief Operating Officer Executive leadership appointment to drive seamless client experiences in patient- servicing and digitally enabled clinical trials

Jun 15, 2022, 01:00 AM by User Not Found

Bio-IT World | While the field of targeted protein degradation (TPD) continues its rapid expansion, with multiple TPD drugs now in clinical trials, researchers in Australia are jumping in at an earlier stage with “tag technology” to ensure the disease protein is worth designing a drug against in the first place. Their work—an extension of other tag-targeting protein degradation technologies—gives researchers the wherewithal to ask if, “the juice is worth the squeeze,” according to Rebecca Feltham, Ph.D., laboratory head in the Ubiquitin Signalling Division of the Walter and Eliza Hall Institute.

Jun 14, 2022, 09:29 AM by

Jun 14, 2022, 01:00 AM by User Not Found

Bio-IT World | A significantly heightened risk of breast cancer has two well-known culprits—mutations to the tumor suppressor genes BRCA1 and BRCA2—but more than 40% of the time they are black-box “variants of uncertain significance.” Using a new data-sharing innovation known as federated analysis, however, an international team of researchers has categorized 16 of these uncertain variants as benign or likely benign so their carriers may be able to have their clinical risk of disease managed properly and avoid the risk of invasive and irrevocable surgeries.

Jun 13, 2022, 09:41 AM by

As per Persistence Market Research’s latest industry analysis, the global medical wellness market was valued at over US$ 1 Tn in 2020, and is expected to exhibit a CAGR of 14.1% over the forecast period (2021-2031).

Jun 10, 2022, 09:03 AM by

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has launched a pre-fillable polymer syringe for low dose applications such as ophthalmic drugs.

Jun 10, 2022, 09:03 AM by

mdgroup recognised as one of the UK's fastest-growing private companies 9 June 2022 - Bracknell, UK: mdgroup has been shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking.

Jun 9, 2022, 09:13 AM by

Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer

Jun 9, 2022, 09:13 AM by

CAMBRIDGE, UK, 08 June 2022: Optibrium™, a developer of software for drug discovery, today announced the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth and ongoing recruitment efforts to support the continued success and development of the company's innovative technology focused on improving the efficiency and productivity of the drug discovery process.

Jun 9, 2022, 09:12 AM by

Medcura, Inc., a commercial-stage life science and medical device company, has appointed James (Jim) Buck as Chief Executive Officer (CEO). A globally connected leader, Buck has been serving as Director at Medcura since 2018 and now fully steps into the CEO role with more than 25 years of highly relevant career experiences.

Jun 9, 2022, 01:00 AM by User Not Found

Bio-IT World | Over the past two years, Stan Gloss, founding partner at BioTeam, has been sitting down with leaders in pharma and biotech for our Trends from the Trenches column and—more recently—the Trends from the Trenches podcast. They have been wide-ranging conversations covering everything from digital transformation at big pharma to All of Us and population genomics, data-driven cancer genomics to AI/ML models in drug discovery.

Jun 8, 2022, 09:18 AM by

Jun 8, 2022, 09:18 AM by

Jun 8, 2022, 09:18 AM by

Diurnal Group plc (AIM: DNL), will be presenting research findings on the treatment and management of congenital adrenal hyperplasia (CAH) at this year’s American Endocrine Society meeting, ENDO 2022, which will be taking place between 11-14 June 2022 in Atlanta, USA.

Jun 8, 2022, 09:18 AM by

IPS to provide full design, construction management and CQV services for Abzena's new monoclonal antibody (mAb) facility in Sanford, North Carolina.

Jun 8, 2022, 09:18 AM by

Jun 8, 2022, 01:00 AM by User Not Found

Bio-IT World | The pioneering OneK1K study in Australia has identified an immune “fingerprint” of seven autoimmune disorders using single-cell RNA sequencing (scRNA-seq). The general framework, which combines the scRNA-seq data with genotype data to classify individual cells, can be applied to many different diseases.

Jun 7, 2022, 09:10 AM by